LIVN – LivaNova PLC
LIVN — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.18
Margin Of Safety %
-13
Put/Call OI Ratio
0.83
EPS Next Q Diff
0.22
EPS Last/This Y
8.69
EPS This/Next Y
0.36
Price
71.71
Target Price
81.5
Analyst Recom
1.75
Performance Q
7.52
Upside
-40.5%
Beta
0.84
Ticker: LIVN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | LIVN | 64.58 | 0.31 | 0.00 | 223 |
| 2026-04-14 | LIVN | 64.94 | 0.31 | 0.00 | 222 |
| 2026-04-15 | LIVN | 65.12 | 0.32 | 999.99 | 220 |
| 2026-04-16 | LIVN | 64.99 | 0.32 | 0.00 | 220 |
| 2026-04-17 | LIVN | 67.09 | 0.31 | 0.01 | 222 |
| 2026-04-20 | LIVN | 65.79 | 0.32 | 0.00 | 149 |
| 2026-04-21 | LIVN | 64.54 | 0.32 | 0.22 | 149 |
| 2026-04-22 | LIVN | 65.15 | 0.32 | 0.22 | 149 |
| 2026-04-23 | LIVN | 65.16 | 0.32 | 0.22 | 149 |
| 2026-04-24 | LIVN | 64.18 | 0.32 | 0.22 | 149 |
| 2026-04-27 | LIVN | 63.38 | 0.32 | 0.22 | 149 |
| 2026-04-28 | LIVN | 61.28 | 0.31 | 0.32 | 171 |
| 2026-04-29 | LIVN | 58.9 | 0.33 | 0.09 | 173 |
| 2026-04-30 | LIVN | 60.1 | 0.33 | 0.09 | 173 |
| 2026-05-01 | LIVN | 61 | 0.33 | 0.17 | 177 |
| 2026-05-04 | LIVN | 59.06 | 0.33 | 0.17 | 177 |
| 2026-05-05 | LIVN | 57.55 | 0.33 | 0.09 | 181 |
| 2026-05-06 | LIVN | 66.2 | 0.88 | 0.78 | 1590 |
| 2026-05-07 | LIVN | 70.93 | 0.87 | 0.07 | 1622 |
| 2026-05-08 | LIVN | 71.88 | 0.84 | 0.11 | 1662 |
| 2026-05-11 | LIVN | 70.08 | 0.83 | 0.50 | 1673 |
| 2026-05-12 | LIVN | 71.78 | 0.83 | 1.50 | 1676 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | LIVN | 64.57 | 1.9 | 367.3 | 4.21 |
| 2026-04-14 | LIVN | 64.94 | 1.9 | 362.5 | 4.21 |
| 2026-04-15 | LIVN | 65.11 | 1.9 | 361.9 | 4.21 |
| 2026-04-16 | LIVN | 64.99 | 1.9 | 361.0 | 4.21 |
| 2026-04-17 | LIVN | 67.12 | 1.9 | 368.1 | 4.21 |
| 2026-04-20 | LIVN | 65.76 | 1.9 | 357.5 | 4.21 |
| 2026-04-21 | LIVN | 64.53 | 1.9 | 357.7 | 4.21 |
| 2026-04-22 | LIVN | 65.16 | 1.9 | 363.5 | 4.21 |
| 2026-04-23 | LIVN | 65.17 | 1.9 | 361.6 | 4.21 |
| 2026-04-24 | LIVN | 64.19 | 1.9 | 358.4 | 4.21 |
| 2026-04-27 | LIVN | 63.40 | 1.9 | 358.9 | 4.21 |
| 2026-04-28 | LIVN | 61.29 | 1.9 | 354.7 | 4.21 |
| 2026-04-30 | LIVN | 60.10 | 1.9 | 365.6 | 4.21 |
| 2026-05-01 | LIVN | 60.98 | 1.9 | 364.6 | 4.21 |
| 2026-05-04 | LIVN | 59.05 | 1.9 | 355.1 | 4.21 |
| 2026-05-05 | LIVN | 57.60 | 1.9 | 356.4 | 4.21 |
| 2026-05-06 | LIVN | 66.22 | 1.9 | 391.8 | 4.21 |
| 2026-05-07 | LIVN | 70.96 | 4.0 | 375.7 | 4.21 |
| 2026-05-08 | LIVN | 71.88 | 4.0 | 27.9 | 4.21 |
| 2026-05-11 | LIVN | 70.10 | 4.0 | 21.4 | 4.24 |
| 2026-05-12 | LIVN | 71.71 | 4.4 | 31.0 | 4.24 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-14 | LIVN | -0.14 | -0.58 | 5.47 |
| 2026-04-15 | LIVN | -0.14 | -0.58 | 5.47 |
| 2026-04-16 | LIVN | -0.14 | -0.58 | 5.47 |
| 2026-04-17 | LIVN | -0.14 | -0.58 | 5.47 |
| 2026-04-20 | LIVN | -0.14 | 1.77 | 5.47 |
| 2026-04-21 | LIVN | -0.14 | 1.77 | 5.47 |
| 2026-04-22 | LIVN | -0.14 | 1.77 | 5.48 |
| 2026-04-23 | LIVN | -0.11 | 1.77 | 5.48 |
| 2026-04-24 | LIVN | -0.11 | 1.77 | 5.48 |
| 2026-04-27 | LIVN | -0.11 | 1.86 | 5.86 |
| 2026-04-28 | LIVN | -0.11 | 1.86 | 5.86 |
| 2026-04-29 | LIVN | -0.11 | 1.86 | 5.86 |
| 2026-04-30 | LIVN | -0.11 | 1.86 | 5.86 |
| 2026-05-01 | LIVN | -0.11 | 1.86 | 5.86 |
| 2026-05-04 | LIVN | -0.11 | 2.76 | 5.86 |
| 2026-05-05 | LIVN | -0.11 | 2.76 | 5.86 |
| 2026-05-06 | LIVN | -0.11 | 2.76 | 5.86 |
| 2026-05-07 | LIVN | -0.11 | 2.76 | 5.86 |
| 2026-05-08 | LIVN | -0.11 | 2.76 | 5.86 |
| 2026-05-11 | LIVN | -0.11 | 0.30 | 0 |
| 2026-05-12 | LIVN | -0.11 | 0.30 | 6.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.87
Avg. EPS Est. Current Quarter
1.1
Avg. EPS Est. Next Quarter
1.08
Insider Transactions
-0.11
Institutional Transactions
0.3
Beta
0.84
Average Sales Estimate Current Quarter
380
Average Sales Estimate Next Quarter
380
Fair Value
62.65
Quality Score
87
Growth Score
58
Sentiment Score
98
Actual DrawDown %
23.6
Max Drawdown 5-Year %
-63.5
Target Price
81.5
P/E
37.04
Forward P/E
15.47
PEG
1.66
P/S
2.75
P/B
3.25
P/Free Cash Flow
24.48
EPS
1.94
Average EPS Est. Cur. Y
4.24
EPS Next Y. (Est.)
4.6
Target Price Estimates Raised
4
Target Price Estimates Lowered
2
Profit Margin
7.47
Relative Volume
1.11
Return on Equity vs Sector %
-18
Return on Equity vs Industry %
-2.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
31
◆
LIVN
Healthcare
$71.75
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
64.2
Range 1M
91.4%
Sup Dist
4.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
8.9%
EPS NY
9.3%
52W%
95.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+19.4% upside
Upside
+19.4%
Quality
87
MoS
-13%
LivaNova PLCSector: Healthcare
Industry: Medical Devices
Employees: 3300
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova's aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
LIVN
Latest News
—
Caricamento notizie per LIVN…
stock quote shares LIVN – LivaNova PLC Stock Price stock today
news today LIVN – LivaNova PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch LIVN – LivaNova PLC yahoo finance google finance
stock history LIVN – LivaNova PLC invest stock market
stock prices LIVN premarket after hours
ticker LIVN fair value insiders trading